Zhu Y, Liu Z, Qu Y, Zeng J, et al. YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects. Cancer Chemother Pharmacol 2020 Jun 9. pii: 10.1007/s00280-020-04098.
PMID: 32519033